<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2017-05-10" version="227">
<accession>P08581</accession>
<accession>A1L467</accession>
<accession>B5A932</accession>
<accession>E7EQ94</accession>
<accession>O60366</accession>
<accession>Q12875</accession>
<accession>Q9UDX7</accession>
<accession>Q9UPL8</accession>
<name>MET_HUMAN</name>
<protein>
<recommendedName>
<fullName>Hepatocyte growth factor receptor</fullName>
<shortName>HGF receptor</shortName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>HGF/SF receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Met</fullName>
</alternativeName>
<alternativeName>
<fullName>Scatter factor receptor</fullName>
<shortName>SF receptor</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase Met</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MET</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="6379" last="6383">
<title>Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors.</title>
<authorList>
<person name="Park M."/>
<person name="Dean M."/>
<person name="Kaul K."/>
<person name="Braun M.J."/>
<person name="Gonda M.A."/>
<person name="Vande Woude G."/>
</authorList>
<dbReference type="PubMed" id="2819873"/>
<dbReference type="DOI" id="10.1073/pnas.84.18.6379"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="2">
<citation type="submission" date="1990-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Giordano S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2008" name="Arthritis Res. Ther." volume="10" first="R73" last="R73">
<title>Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.</title>
<authorList>
<person name="Jin P."/>
<person name="Zhang J."/>
<person name="Sumariwalla P.F."/>
<person name="Ni I."/>
<person name="Jorgensen B."/>
<person name="Crawford D."/>
<person name="Phillips S."/>
<person name="Feldmann M."/>
<person name="Shepard H.M."/>
<person name="Paleolog E.M."/>
</authorList>
<dbReference type="PubMed" id="18593464"/>
<dbReference type="DOI" id="10.1186/ar2447"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Nature" volume="424" first="157" last="164">
<title>The DNA sequence of human chromosome 7.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Graves T.A."/>
<person name="Pepin K.H."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Maas J."/>
<person name="Jaeger S."/>
<person name="Walker R."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="O'Laughlin M.D."/>
<person name="Schaller M.E."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Cordes M."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Edwards J."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Andrews S."/>
<person name="Isak A."/>
<person name="Vanbrunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Lamar B."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Bielicki L."/>
<person name="Scott K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Harris A."/>
<person name="Strong C.M."/>
<person name="Hou S."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Leonard S."/>
<person name="Rohlfing T."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Abbott A."/>
<person name="Minx P."/>
<person name="Maupin R."/>
<person name="Strowmatt C."/>
<person name="Latreille P."/>
<person name="Miller N."/>
<person name="Johnson D."/>
<person name="Murray J."/>
<person name="Woessner J.P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Schultz B.R."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Nelson J.O."/>
<person name="Berkowicz N."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Bedell J.A."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Chissoe S.L."/>
<person name="Marra M.A."/>
<person name="Raymond C."/>
<person name="Haugen E."/>
<person name="Gillett W."/>
<person name="Zhou Y."/>
<person name="James R."/>
<person name="Phelps K."/>
<person name="Iadanoto S."/>
<person name="Bubb K."/>
<person name="Simms E."/>
<person name="Levy R."/>
<person name="Clendenning J."/>
<person name="Kaul R."/>
<person name="Kent W.J."/>
<person name="Furey T.S."/>
<person name="Baertsch R.A."/>
<person name="Brent M.R."/>
<person name="Keibler E."/>
<person name="Flicek P."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Bailey J.A."/>
<person name="Portnoy M.E."/>
<person name="Torrents D."/>
<person name="Chinwalla A.T."/>
<person name="Gish W.R."/>
<person name="Eddy S.R."/>
<person name="McPherson J.D."/>
<person name="Olson M.V."/>
<person name="Eichler E.E."/>
<person name="Green E.D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="12853948"/>
<dbReference type="DOI" id="10.1038/nature01782"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Science" volume="300" first="767" last="772">
<title>Human chromosome 7: DNA sequence and biology.</title>
<authorList>
<person name="Scherer S.W."/>
<person name="Cheung J."/>
<person name="MacDonald J.R."/>
<person name="Osborne L.R."/>
<person name="Nakabayashi K."/>
<person name="Herbrick J.-A."/>
<person name="Carson A.R."/>
<person name="Parker-Katiraee L."/>
<person name="Skaug J."/>
<person name="Khaja R."/>
<person name="Zhang J."/>
<person name="Hudek A.K."/>
<person name="Li M."/>
<person name="Haddad M."/>
<person name="Duggan G.E."/>
<person name="Fernandez B.A."/>
<person name="Kanematsu E."/>
<person name="Gentles S."/>
<person name="Christopoulos C.C."/>
<person name="Choufani S."/>
<person name="Kwasnicka D."/>
<person name="Zheng X.H."/>
<person name="Lai Z."/>
<person name="Nusskern D.R."/>
<person name="Zhang Q."/>
<person name="Gu Z."/>
<person name="Lu F."/>
<person name="Zeesman S."/>
<person name="Nowaczyk M.J."/>
<person name="Teshima I."/>
<person name="Chitayat D."/>
<person name="Shuman C."/>
<person name="Weksberg R."/>
<person name="Zackai E.H."/>
<person name="Grebe T.A."/>
<person name="Cox S.R."/>
<person name="Kirkpatrick S.J."/>
<person name="Rahman N."/>
<person name="Friedman J.M."/>
<person name="Heng H.H.Q."/>
<person name="Pelicci P.G."/>
<person name="Lo-Coco F."/>
<person name="Belloni E."/>
<person name="Shaffer L.G."/>
<person name="Pober B."/>
<person name="Morton C.C."/>
<person name="Gusella J.F."/>
<person name="Bruns G.A.P."/>
<person name="Korf B.R."/>
<person name="Quade B.J."/>
<person name="Ligon A.H."/>
<person name="Ferguson H."/>
<person name="Higgins A.W."/>
<person name="Leach N.T."/>
<person name="Herrick S.R."/>
<person name="Lemyre E."/>
<person name="Farra C.G."/>
<person name="Kim H.-G."/>
<person name="Summers A.M."/>
<person name="Gripp K.W."/>
<person name="Roberts W."/>
<person name="Szatmari P."/>
<person name="Winsor E.J.T."/>
<person name="Grzeschik K.-H."/>
<person name="Teebi A."/>
<person name="Minassian B.A."/>
<person name="Kere J."/>
<person name="Armengol L."/>
<person name="Pujana M.A."/>
<person name="Estivill X."/>
<person name="Wilson M.D."/>
<person name="Koop B.F."/>
<person name="Tosi S."/>
<person name="Moore G.E."/>
<person name="Boright A.P."/>
<person name="Zlotorynski E."/>
<person name="Kerem B."/>
<person name="Kroisel P.M."/>
<person name="Petek E."/>
<person name="Oscier D.G."/>
<person name="Mould S.J."/>
<person name="Doehner H."/>
<person name="Doehner K."/>
<person name="Rommens J.M."/>
<person name="Vincent J.B."/>
<person name="Venter J.C."/>
<person name="Li P.W."/>
<person name="Mural R.J."/>
<person name="Adams M.D."/>
<person name="Tsui L.-C."/>
</authorList>
<dbReference type="PubMed" id="12690205"/>
<dbReference type="DOI" id="10.1126/science.1083423"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1987" name="Oncogene" volume="1" first="229" last="233">
<title>Primary structure of the met protein tyrosine kinase domain.</title>
<authorList>
<person name="Chan A.M.-L."/>
<person name="King H.W.S."/>
<person name="Tempest P.R."/>
<person name="Deakin E.A."/>
<person name="Cooper C.S."/>
<person name="Brookes P."/>
</authorList>
<dbReference type="PubMed" id="3325883"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1010-1390</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Oncogene" volume="8" first="3403" last="3410">
<title>A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes.</title>
<authorList>
<person name="Lee S.-T."/>
<person name="Strunk K.M."/>
<person name="Spritz R.A."/>
</authorList>
<dbReference type="PubMed" id="8247543"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1206-1264</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1985" name="Nature" volume="318" first="385" last="388">
<title>The human met oncogene is related to the tyrosine kinase oncogenes.</title>
<authorList>
<person name="Dean M."/>
<person name="Park M."/>
<person name="le Beau M.M."/>
<person name="Robins T.S."/>
<person name="Diaz M.O."/>
<person name="Rowley J.D."/>
<person name="Blair D.G."/>
<person name="Vande Woude G.F."/>
</authorList>
<dbReference type="PubMed" id="4069211"/>
<dbReference type="DOI" id="10.1038/318385a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1267-1390</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1991" name="Int. J. Cancer" volume="49" first="323" last="328">
<title>The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors.</title>
<authorList>
<person name="Prat M."/>
<person name="Narsimhan R.P."/>
<person name="Crepaldi T."/>
<person name="Nicotra M.R."/>
<person name="Natali P.G."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="1917129"/>
<dbReference type="DOI" id="10.1002/ijc.2910490302"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="22087" last="22090">
<title>The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase.</title>
<authorList>
<person name="Graziani A."/>
<person name="Gramaglia D."/>
<person name="Cantley L.C."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="1718989"/>
</citation>
<scope>INTERACTION WITH PIK3R1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="Oncogene" volume="6" first="1997" last="2003">
<title>Expression of the Met/HGF receptor in normal and neoplastic human tissues.</title>
<authorList>
<person name="Di Renzo M.F."/>
<person name="Narsimhan R.P."/>
<person name="Olivero M."/>
<person name="Bretti S."/>
<person name="Giordano S."/>
<person name="Medico E."/>
<person name="Gaglia P."/>
<person name="Zara P."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="1719465"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="Science" volume="251" first="802" last="804">
<title>Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.</title>
<authorList>
<person name="Bottaro D.P."/>
<person name="Rubin J.S."/>
<person name="Faletto D.L."/>
<person name="Chan A.M.-L."/>
<person name="Kmiecik T.E."/>
<person name="Vande Woude G.F."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="1846706"/>
<dbReference type="DOI" id="10.1126/science.1846706"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="19558" last="19564">
<title>Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kinase.</title>
<authorList>
<person name="Ferracini R."/>
<person name="Longati P."/>
<person name="Naldini L."/>
<person name="Vigna E."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="1655790"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1235</scope>
<scope>ATP-BINDING SITE LYS-1110</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1994" name="Cell" volume="77" first="261" last="271">
<title>A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.</title>
<authorList>
<person name="Ponzetto C."/>
<person name="Bardelli A."/>
<person name="Zhen Z."/>
<person name="Maina F."/>
<person name="dalla Zonca P."/>
<person name="Giordano S."/>
<person name="Graziani A."/>
<person name="Panayotou G."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="7513258"/>
<dbReference type="DOI" id="10.1016/0092-8674(94)90318-2"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1349 AND TYR-1356</scope>
<scope>INTERACTION WITH SRC; PLCG1 AND GRB2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="93" first="2056" last="2065">
<title>Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium.</title>
<authorList>
<person name="Nusrat A."/>
<person name="Parkos C.A."/>
<person name="Bacarra A.E."/>
<person name="Godowski P.J."/>
<person name="Delp-Archer C."/>
<person name="Rosen E.M."/>
<person name="Madara J.L."/>
</authorList>
<dbReference type="PubMed" id="8182137"/>
<dbReference type="DOI" id="10.1172/JCI117200"/>
</citation>
<scope>FUNCTION IN WOUND HEALING</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Nature" volume="391" first="285" last="288">
<title>Induction of epithelial tubules by growth factor HGF depends on the STAT pathway.</title>
<authorList>
<person name="Boccaccio C."/>
<person name="Ando M."/>
<person name="Tamagnone L."/>
<person name="Bardelli A."/>
<person name="Michieli P."/>
<person name="Battistini C."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="9440692"/>
<dbReference type="DOI" id="10.1038/34657"/>
</citation>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="6217" last="6228">
<title>Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.</title>
<authorList>
<person name="Wang J."/>
<person name="Dai H."/>
<person name="Yousaf N."/>
<person name="Moussaif M."/>
<person name="Deng Y."/>
<person name="Boufelliga A."/>
<person name="Swamy O.R."/>
<person name="Leone M.E."/>
<person name="Riedel H."/>
</authorList>
<dbReference type="PubMed" id="10454568"/>
<dbReference type="DOI" id="10.1128/MCB.19.9.6217"/>
</citation>
<scope>INTERACTION WITH GRB10</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="36216" last="36222">
<title>Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.</title>
<authorList>
<person name="Wang D."/>
<person name="Li Z."/>
<person name="Messing E.M."/>
<person name="Wu G."/>
</authorList>
<dbReference type="PubMed" id="12147692"/>
<dbReference type="DOI" id="10.1074/jbc.M205111200"/>
</citation>
<scope>INTERACTION WITH RANBP9</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2002" name="J. Immunol." volume="169" first="3793" last="3800">
<title>c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.</title>
<authorList>
<person name="Taher T.E."/>
<person name="Tjin E.P."/>
<person name="Beuling E.A."/>
<person name="Borst J."/>
<person name="Spaargaren M."/>
<person name="Pals S.T."/>
</authorList>
<dbReference type="PubMed" id="12244174"/>
<dbReference type="DOI" id="10.4049/jimmunol.169.7.3793"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF TYR-1234; TYR-1235; TYR-1313; TYR-1349; TYR-1356 AND TYR-1365</scope>
<scope>CHARACTERIZATION OF VARIANT SER-1003</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2002" name="Nat. Cell Biol." volume="4" first="720" last="724">
<title>The semaphorin 4D receptor controls invasive growth by coupling with Met.</title>
<authorList>
<person name="Giordano S."/>
<person name="Corso S."/>
<person name="Conrotto P."/>
<person name="Artigiani S."/>
<person name="Gilestro G."/>
<person name="Barberis D."/>
<person name="Tamagnone L."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="12198496"/>
<dbReference type="DOI" id="10.1038/ncb843"/>
</citation>
<scope>INTERACTION WITH PLXNB1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="5728" last="5735">
<title>Hepatocyte growth factor receptor tyrosine kinase met is a substrate of the receptor protein-tyrosine phosphatase DEP-1.</title>
<authorList>
<person name="Palka H.L."/>
<person name="Park M."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="12475979"/>
<dbReference type="DOI" id="10.1074/jbc.M210656200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1230; TYR-1234; TYR-1235; TYR-1349 AND TYR-1365</scope>
<scope>DEPHOSPHORYLATION AT TYR-1349 AND TYR-1365 BY PTPRJ</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="313" first="320" last="326">
<title>A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.</title>
<authorList>
<person name="Wang D."/>
<person name="Li Z."/>
<person name="Schoen S.R."/>
<person name="Messing E.M."/>
<person name="Wu G."/>
</authorList>
<dbReference type="PubMed" id="14684163"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.11.124"/>
</citation>
<scope>INTERACTION WITH RANBP9 AND RANBP10</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="7456" last="7468">
<title>MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met.</title>
<authorList>
<person name="Higuchi T."/>
<person name="Orita T."/>
<person name="Katsuya K."/>
<person name="Yamasaki Y."/>
<person name="Akiyama K."/>
<person name="Li H."/>
<person name="Yamamoto T."/>
<person name="Saito Y."/>
<person name="Nakamura M."/>
</authorList>
<dbReference type="PubMed" id="15314156"/>
<dbReference type="DOI" id="10.1128/MCB.24.17.7456-7468.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MUC20</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="3436" last="3447">
<title>The SH2-domain-containing inositol 5-phosphatase (SHIP)-2 binds to c-Met directly via tyrosine residue 1356 and involves hepatocyte growth factor (HGF)-induced lamellipodium formation, cell scattering and cell spreading.</title>
<authorList>
<person name="Koch A."/>
<person name="Mancini A."/>
<person name="El Bounkari O."/>
<person name="Tamura T."/>
</authorList>
<dbReference type="PubMed" id="15735664"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208558"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1356</scope>
<scope>INTERACTION WITH INPPL1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Nat. Rev. Cancer" volume="6" first="637" last="645">
<title>Invasive growth: a MET-driven genetic programme for cancer and stem cells.</title>
<authorList>
<person name="Boccaccio C."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="16862193"/>
<dbReference type="DOI" id="10.1038/nrc1912"/>
</citation>
<scope>REVIEW ON FUNCTION IN ANGIOGENESIS</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="34374" last="34383">
<title>Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.</title>
<authorList>
<person name="Sangwan V."/>
<person name="Paliouras G.N."/>
<person name="Abella J.V."/>
<person name="Dube N."/>
<person name="Monast A."/>
<person name="Tremblay M.L."/>
<person name="Park M."/>
</authorList>
<dbReference type="PubMed" id="18819921"/>
<dbReference type="DOI" id="10.1074/jbc.M805916200"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN1 AND PTPN2</scope>
<scope>INTERACTION WITH PTPN1 AND PTPN2</scope>
<scope>MUTAGENESIS OF TYR-1234 AND TYR-1235</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-977 AND TYR-1003</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-990; SER-997 AND SER-1000</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="662" last="672">
<title>Identification of N-glycosylation sites on secreted proteins of human hepatocellular carcinoma cells with a complementary proteomics approach.</title>
<authorList>
<person name="Cao J."/>
<person name="Shen C."/>
<person name="Wang H."/>
<person name="Shen H."/>
<person name="Chen Y."/>
<person name="Nie A."/>
<person name="Yan G."/>
<person name="Lu H."/>
<person name="Liu Y."/>
<person name="Yang P."/>
</authorList>
<dbReference type="PubMed" id="19196183"/>
<dbReference type="DOI" id="10.1021/pr800826u"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-106</scope>
<source>
<tissue>Hepatoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1003 AND THR-1289</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="Biochim. Biophys. Acta" volume="1806" first="208" last="219">
<title>The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.</title>
<authorList>
<person name="Mahtouk K."/>
<person name="Tjin E.P."/>
<person name="Spaargaren M."/>
<person name="Pals S.T."/>
</authorList>
<dbReference type="PubMed" id="20655987"/>
<dbReference type="DOI" id="10.1016/j.bbcan.2010.07.006"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="32762" last="32774">
<title>Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.</title>
<authorList>
<person name="Chaudhuri A."/>
<person name="Xie M.H."/>
<person name="Yang B."/>
<person name="Mahapatra K."/>
<person name="Liu J."/>
<person name="Marsters S."/>
<person name="Bodepudi S."/>
<person name="Ashkenazi A."/>
</authorList>
<dbReference type="PubMed" id="21784853"/>
<dbReference type="DOI" id="10.1074/jbc.M111.239384"/>
</citation>
<scope>INTERACTION WITH GAB1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-990</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-966</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Am. J. Hum. Genet." volume="97" first="837" last="847">
<title>Mutations preventing regulated exon skipping in MET cause osteofibrous dysplasia.</title>
<authorList>
<person name="Gray M.J."/>
<person name="Kannu P."/>
<person name="Sharma S."/>
<person name="Neyt C."/>
<person name="Zhang D."/>
<person name="Paria N."/>
<person name="Daniel P.B."/>
<person name="Whetstone H."/>
<person name="Sprenger H.G."/>
<person name="Hammerschmidt P."/>
<person name="Weng A."/>
<person name="Dupuis L."/>
<person name="Jobling R."/>
<person name="Mendoza-Londono R."/>
<person name="Dray M."/>
<person name="Su P."/>
<person name="Wilson M.J."/>
<person name="Kapur R.P."/>
<person name="McCarthy E.F."/>
<person name="Alman B.A."/>
<person name="Howard A."/>
<person name="Somers G.R."/>
<person name="Marshall C.R."/>
<person name="Manners S."/>
<person name="Flanagan A.M."/>
<person name="Rathjen K.E."/>
<person name="Karol L.A."/>
<person name="Crawford H."/>
<person name="Markie D.M."/>
<person name="Rios J.J."/>
<person name="Wise C.A."/>
<person name="Robertson S.P."/>
</authorList>
<dbReference type="PubMed" id="26637977"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2015.11.001"/>
</citation>
<scope>INVOLVEMENT IN OSFD</scope>
<scope>VARIANT OSFD 964-LEU--ASP-1010 DEL</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="J. Med. Genet." volume="52" first="548" last="552">
<title>A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.</title>
<authorList>
<person name="Mujtaba G."/>
<person name="Schultz J.M."/>
<person name="Imtiaz A."/>
<person name="Morell R.J."/>
<person name="Friedman T.B."/>
<person name="Naz S."/>
</authorList>
<dbReference type="PubMed" id="25941349"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2015-103023"/>
</citation>
<scope>INVOLVEMENT IN DFNB97</scope>
<scope>VARIANT DFNB97 VAL-841</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0141786" last="E0141786">
<title>Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants.</title>
<authorList>
<person name="Prince T.L."/>
<person name="Kijima T."/>
<person name="Tatokoro M."/>
<person name="Lee S."/>
<person name="Tsutsumi S."/>
<person name="Yim K."/>
<person name="Rivas C."/>
<person name="Alarcon S."/>
<person name="Schwartz H."/>
<person name="Khamit-Kush K."/>
<person name="Scroggins B.T."/>
<person name="Beebe K."/>
<person name="Trepel J.B."/>
<person name="Neckers L."/>
</authorList>
<dbReference type="PubMed" id="26517842"/>
<dbReference type="DOI" id="10.1371/journal.pone.0141786"/>
</citation>
<scope>INTERACTION WITH HSP90AA1 AND HSP90AB1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2016" name="J. Biol. Chem." volume="291" first="17133" last="17142">
<title>Crystal structure of human leukocyte cell-derived chemotaxin 2 (LECT2) reveals a mechanistic basis of functional evolution in a mammalian protein with an M23 metalloendopeptidase fold.</title>
<authorList>
<person name="Zheng H."/>
<person name="Miyakawa T."/>
<person name="Sawano Y."/>
<person name="Asano A."/>
<person name="Okumura A."/>
<person name="Yamagoe S."/>
<person name="Tanokura M."/>
</authorList>
<dbReference type="PubMed" id="27334921"/>
<dbReference type="DOI" id="10.1074/jbc.M116.720375"/>
</citation>
<scope>INTERACTION WITH LECT2</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Biochemistry" volume="39" first="13376" last="13382">
<title>Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.</title>
<authorList>
<person name="Schiering N."/>
<person name="Casale E."/>
<person name="Caccia P."/>
<person name="Giordano P."/>
<person name="Battistini C."/>
</authorList>
<dbReference type="PubMed" id="11063574"/>
<dbReference type="DOI" id="10.1021/bi0012336"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1356-1359 IN COMPLEX WITH GRB2</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="12654" last="12659">
<title>Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.</title>
<authorList>
<person name="Schiering N."/>
<person name="Knapp S."/>
<person name="Marconi M."/>
<person name="Flocco M.M."/>
<person name="Cui J."/>
<person name="Perego R."/>
<person name="Rusconi L."/>
<person name="Cristiani C."/>
</authorList>
<dbReference type="PubMed" id="14559966"/>
<dbReference type="DOI" id="10.1073/pnas.1734128100"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1049-1360 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="321" first="234" last="240">
<title>Insights into function of PSI domains from structure of the Met receptor PSI domain.</title>
<authorList>
<person name="Kozlov G."/>
<person name="Perreault A."/>
<person name="Schrag J.D."/>
<person name="Park M."/>
<person name="Cygler M."/>
<person name="Gehring K."/>
<person name="Ekiel I."/>
</authorList>
<dbReference type="PubMed" id="15358240"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.06.132"/>
</citation>
<scope>STRUCTURE BY NMR OF 519-562</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="2325" last="2335">
<title>Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor.</title>
<authorList>
<person name="Stamos J."/>
<person name="Lazarus R.A."/>
<person name="Yao X."/>
<person name="Kirchhofer D."/>
<person name="Wiesmann C."/>
</authorList>
<dbReference type="PubMed" id="15167892"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600243"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.22 ANGSTROMS) OF 25-567 IN COMPLEX WITH HGF</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2007" name="Cell" volume="130" first="235" last="246">
<title>Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB.</title>
<authorList>
<person name="Niemann H.H."/>
<person name="Jager V."/>
<person name="Butler P.J."/>
<person name="van den Heuvel J."/>
<person name="Schmidt S."/>
<person name="Ferraris D."/>
<person name="Gherardi E."/>
<person name="Heinz D.W."/>
</authorList>
<dbReference type="PubMed" id="17662939"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.05.037"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-740 IN COMPLEX WITH L.MONOCYTOGENES INLB</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="68" last="73">
<title>Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.</title>
<authorList>
<person name="Schmidt L."/>
<person name="Duh F.-M."/>
<person name="Chen F."/>
<person name="Kishida T."/>
<person name="Glenn G."/>
<person name="Choyke P."/>
<person name="Scherer S.W."/>
<person name="Zhuang Z."/>
<person name="Lubensky I."/>
<person name="Dean M."/>
<person name="Allikmets R."/>
<person name="Chidambaram A."/>
<person name="Bergerheim U.R."/>
<person name="Feltis J.T."/>
<person name="Casadevall C."/>
<person name="Zamarron A."/>
<person name="Bernues M."/>
<person name="Richard S."/>
<person name="Lips C.J.M."/>
<person name="Walther M.M."/>
<person name="Tsui L.-C."/>
<person name="Geil L."/>
<person name="Orcutt M.L."/>
<person name="Stackhouse T."/>
<person name="Lipan J."/>
<person name="Slife L."/>
<person name="Brauch H."/>
<person name="Decker J."/>
<person name="Niehans G."/>
<person name="Hughson M.D."/>
<person name="Moch H."/>
<person name="Storkel S."/>
<person name="Lerman M.I."/>
<person name="Linehan W.M."/>
<person name="Zbar B."/>
</authorList>
<dbReference type="PubMed" id="9140397"/>
<dbReference type="DOI" id="10.1038/ng0597-68"/>
</citation>
<scope>VARIANTS RCCP THR-1131; LEU-1188; VAL-1195; ILE-1220; HIS-1228; ASN-1228; CYS-1230; HIS-1230 AND THR-1250</scope>
<scope>VARIANT VAL-320</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="1719" last="1722">
<title>Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene.</title>
<authorList>
<person name="Schmidt L."/>
<person name="Junker K."/>
<person name="Weirich G."/>
<person name="Glenn G."/>
<person name="Choyke P."/>
<person name="Lubensky I."/>
<person name="Zhuang Z."/>
<person name="Jeffers M."/>
<person name="Vande Woude G."/>
<person name="Neumann H."/>
<person name="Walther M."/>
<person name="Linehan W.M."/>
<person name="Zbar B."/>
</authorList>
<dbReference type="PubMed" id="9563489"/>
</citation>
<scope>VARIANT RCCP ARG-1094</scope>
<scope>CHARACTERIZATION OF VARIANT RCCP ARG-1094</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1999" name="Am. J. Pathol." volume="155" first="517" last="526">
<title>Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype.</title>
<authorList>
<person name="Lubensky I.A."/>
<person name="Schmidt L."/>
<person name="Zhuang Z."/>
<person name="Weirich G."/>
<person name="Pack S."/>
<person name="Zambrano N."/>
<person name="Walther M.M."/>
<person name="Choyke P."/>
<person name="Linehan W.M."/>
<person name="Zbar B."/>
</authorList>
<dbReference type="PubMed" id="10433944"/>
<dbReference type="DOI" id="10.1016/S0002-9440(10)65147-4"/>
</citation>
<scope>VARIANTS RCCP ILE-1092; ARG-1094; ASP-1106; THR-1131; LEU-1188; ASP-1230; CYS-1230 AND THR-1250</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1999" name="Cancer Res." volume="59" first="307" last="310">
<title>Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas.</title>
<authorList>
<person name="Park W.S."/>
<person name="Dong S.M."/>
<person name="Kim S.Y."/>
<person name="Na E.Y."/>
<person name="Shin M.S."/>
<person name="Pi J.H."/>
<person name="Kim B.J."/>
<person name="Bae J.H."/>
<person name="Hong Y.K."/>
<person name="Lee K.S."/>
<person name="Lee S.H."/>
<person name="Yoo N.J."/>
<person name="Jang J.J."/>
<person name="Pack S."/>
<person name="Zhuang Z."/>
<person name="Schmidt L."/>
<person name="Zbar B."/>
<person name="Lee J.Y."/>
</authorList>
<dbReference type="PubMed" id="9927037"/>
</citation>
<scope>VARIANTS HCC ILE-1173; ARG-1244 AND ILE-1250</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="82" first="640" last="643">
<title>Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.</title>
<authorList>
<person name="Olivero M."/>
<person name="Valente G."/>
<person name="Bardelli A."/>
<person name="Longati P."/>
<person name="Ferrero N."/>
<person name="Cracco C."/>
<person name="Terrone C."/>
<person name="Rocca-Rossetti S."/>
<person name="Comoglio P.M."/>
<person name="Di Renzo M.F."/>
</authorList>
<dbReference type="PubMed" id="10417759"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19990827)82:5&lt;640::AID-IJC4>3.0.CO;2-6"/>
</citation>
<scope>VARIANT RCCP ILE-1092</scope>
<scope>CHARACTERIZATION OF VARIANT RCCP ILE-1092</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="2343" last="2350">
<title>Novel mutations of the MET proto-oncogene in papillary renal carcinomas.</title>
<authorList>
<person name="Schmidt L."/>
<person name="Junker K."/>
<person name="Nakaigawa N."/>
<person name="Kinjerski T."/>
<person name="Weirich G."/>
<person name="Miller M."/>
<person name="Lubensky I."/>
<person name="Neumann H.P.H."/>
<person name="Brauch H."/>
<person name="Decker J."/>
<person name="Vocke C."/>
<person name="Brown J.A."/>
<person name="Jenkins R."/>
<person name="Richard S."/>
<person name="Bergerheim U."/>
<person name="Gerrard B."/>
<person name="Dean M."/>
<person name="Linehan W.M."/>
<person name="Zbar B."/>
</authorList>
<dbReference type="PubMed" id="10327054"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202547"/>
</citation>
<scope>VARIANTS RCCP ILE-1092; LEU-1094; TYR-1094; ASP-1106 AND ASP-1230</scope>
<scope>CHARACTERIZATION OF VARIANTS RCCP ILE-1092; LEU-1094; TYR-1094; ASP-1106 AND ASP-1230</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="4947" last="4953">
<title>A novel germ line juxtamembrane Met mutation in human gastric cancer.</title>
<authorList>
<person name="Lee J.-H."/>
<person name="Han S.-U."/>
<person name="Cho H."/>
<person name="Jennings B."/>
<person name="Gerrard B."/>
<person name="Dean M."/>
<person name="Schmidt L."/>
<person name="Zbar B."/>
<person name="Vande Woude G.F.V."/>
</authorList>
<dbReference type="PubMed" id="11042681"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203874"/>
</citation>
<scope>VARIANT GASTRIC CANCER SER-991</scope>
<scope>VARIANT ILE-992</scope>
<scope>CHARACTERIZATION OF VARIANT GASTRIC CANCER SER-991</scope>
<scope>CHARACTERIZATION OF VARIANT ILE-992</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="E97" last="E97">
<title>A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer.</title>
<authorList>
<person name="Kim I.-J."/>
<person name="Park J.-H."/>
<person name="Kang H.C."/>
<person name="Shin Y."/>
<person name="Lim S.-B."/>
<person name="Ku J.-L."/>
<person name="Yang H.-K."/>
<person name="Lee K.U."/>
<person name="Park J.-G."/>
</authorList>
<dbReference type="PubMed" id="12920089"/>
<dbReference type="DOI" id="10.1136/jmg.40.8.e97"/>
</citation>
<scope>VARIANT GASTRIC CANCER LEU-773</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="16393" last="16401">
<title>The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.</title>
<authorList>
<person name="Wang D."/>
<person name="Li Z."/>
<person name="Messing E.M."/>
<person name="Wu G."/>
</authorList>
<dbReference type="PubMed" id="15713673"/>
<dbReference type="DOI" id="10.1074/jbc.M413897200"/>
</citation>
<scope>INTERACTION WITH SPSB1; SPSB2; SPSB3 AND SPSB4</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="16834" last="16839">
<title>A genetic variant that disrupts MET transcription is associated with autism.</title>
<authorList>
<person name="Campbell D.B."/>
<person name="Sutcliffe J.S."/>
<person name="Ebert P.J."/>
<person name="Militerni R."/>
<person name="Bravaccio C."/>
<person name="Trillo S."/>
<person name="Elia M."/>
<person name="Schneider C."/>
<person name="Melmed R."/>
<person name="Sacco R."/>
<person name="Persico A.M."/>
<person name="Levitt P."/>
</authorList>
<dbReference type="PubMed" id="17053076"/>
<dbReference type="DOI" id="10.1073/pnas.0605296103"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO AUTS9</scope>
<scope>VARIANTS CYS-970 AND ILE-992</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLN-143; LEU-156; ASP-168; SER-375; CYS-970 AND ILE-992</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="44" last="50">
<title>MET mutations in cancers of unknown primary origin (CUPs).</title>
<authorList>
<person name="Stella G.M."/>
<person name="Benvenuti S."/>
<person name="Gramaglia D."/>
<person name="Scarpa A."/>
<person name="Tomezzoli A."/>
<person name="Cassoni P."/>
<person name="Senetta R."/>
<person name="Venesio T."/>
<person name="Pozzi E."/>
<person name="Bardelli A."/>
<person name="Comoglio P.M."/>
</authorList>
<dbReference type="PubMed" id="20949619"/>
<dbReference type="DOI" id="10.1002/humu.21374"/>
</citation>
<scope>VARIANTS TYR-150; ASP-168; TYR-385; ILE-992 AND ILE-1294</scope>
<scope>CHARACTERIZATION OF VARIANTS TYR-150; ASP-168; TYR-385; ILE-992 AND ILE-1294</scope>
<scope>POSSIBLE INVOLVEMENT IN CUP</scope>
</reference>
<comment type="function">
<text evidence="16">Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis (By similarity).</text>
</comment>
<comment type="function">
<text>Acts as a receptor for Listeria internalin inlB, mediating entry of the pathogen into cells.</text>
</comment>
<comment type="catalytic activity">
<text evidence="20">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text>In its inactive state, the C-terminal tail interacts with the catalytic domain and inhibits the kinase activity. Upon ligand binding, the C-terminal tail is displaced and becomes phosphorylated, thus increasing the kinase activity.</text>
</comment>
<comment type="subunit">
<text evidence="16 24 26 27 28 32 33 34 35 36 37 40 43 44 48 50 52 53 55">Heterodimer made of an alpha chain (50 kDa) and a beta chain (145 kDa) which are disulfide linked. Binds PLXNB1. Interacts when phosphorylated with downstream effectors including STAT3, PIK3R1, SRC, PCLG1, GRB2 and GAB1. Interacts with SPSB1, SPSB2 and SPSB4 (By similarity). Interacts with INPP5D/SHIP1. When phosphorylated at Tyr-1356, interacts with INPPL1/SHIP2. Interacts with RANBP9 and RANBP10, as well as SPSB1, SPSB2, SPSB3 and SPSB4. SPSB1 binding occurs in the presence and in the absence of HGF, however HGF treatment has a positive effect on this interaction. Interacts with MUC20; prevents interaction with GRB2 and suppresses hepatocyte growth factor-induced cell proliferation. Interacts with GRB10. Interacts with PTPN1 and PTPN2. Interacts with LECT2; this interaction may have an antagonistic effect on receptor activation (PubMed:27334921). Interacts with HSP90AA1 and HSP90AB1; the interaction suppresses MET kinase activity (PubMed:26517842).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-3952284">
<id>Q96EY1-2</id>
<label>DNAJA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1039104">
<id>P14210</id>
<label>HGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-6280319">
<id>P14210-6</id>
<label>HGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1379295">
<id>P25147</id>
<label>inlB</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1384248">
<id>O15357</id>
<label>INPPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1005487">
<id>P35968</id>
<label>KDR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1555005">
<id>P35918</id>
<label>Kdr</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1348">
<id>P06239</id>
<label>LCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-2804728">
<id>P15941</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1111488">
<id>O43157</id>
<label>PLXNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-722004">
<id>O15031</id>
<label>PLXNB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-311073">
<id>Q9ULL4</id>
<label>PLXNB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-2896409">
<id>Q00944</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1265766">
<id>P23467</id>
<label>PTPRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-6983382">
<id>O60880</id>
<label>SH2D1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-3923013">
<id>O14796</id>
<label>SH2D1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-745980">
<id>Q8N5H7</id>
<label>SH2D3C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-4402156">
<id>Q15464</id>
<label>SHB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-4402781">
<id>Q96IW2</id>
<label>SHD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1222854">
<id>Q9H6Q3</id>
<label>SLA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-970130">
<id>O75159</id>
<label>SOCS5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-3929549">
<id>O14544</id>
<label>SOCS6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-6083058">
<id>Q9ULZ2</id>
<label>STAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1383480">
<id>P42680</id>
<label>TEC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-3389814">
<id>Q9HBL0</id>
<label>TNS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-297568">
<id>Q9UKW4</id>
<label>VAV3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1039152"/>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P08581-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P08581-2</id>
<name>2</name>
<sequence type="described" ref="VSP_005005"/>
<text>No experimental confirmation available.</text>
</isoform>
<isoform>
<id>P08581-3</id>
<name>3</name>
<name>Soluble MET variant 4</name>
<sequence type="described" ref="VSP_042447 VSP_042448"/>
</isoform>
<text>Additional soluble isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text evidence="41 45 51">Expressed in normal hepatocytes as well as in epithelial cells lining the stomach, the small and the large intestine. Found also in basal keratinocytes of esophagus and skin. High levels are found in liver, gastrointestinal tract, thyroid and kidney. Also present in the brain. Expressed in metaphyseal bone (at protein level) (PubMed:26637977).</text>
</comment>
<comment type="domain">
<text>The kinase domain is involved in SPSB1 binding.</text>
</comment>
<comment type="domain">
<text>The beta-propeller Sema domain mediates binding to HGF.</text>
</comment>
<comment type="PTM">
<text evidence="30 37 38 44 53">Autophosphorylated in response to ligand binding on Tyr-1234 and Tyr-1235 in the kinase domain leading to further phosphorylation of Tyr-1349 and Tyr-1356 in the C-terminal multifunctional docking site. Dephosphorylated by PTPRJ at Tyr-1349 and Tyr-1365. Dephosphorylated by PTPN1 and PTPN2.</text>
</comment>
<comment type="PTM">
<text evidence="29 61">Ubiquitinated. Ubiquitination by CBL regulates MET endocytosis, resulting in decreasing plasma membrane receptor abundance, and in endosomal degradation and/or recycling of internalized receptors.</text>
</comment>
<comment type="disease">
<text>Activation of MET after rearrangement with the TPR gene produces an oncogenic protein.</text>
</comment>
<comment type="disease">
<text>Defects in MET may be associated with gastric cancer.</text>
</comment>
<comment type="disease" evidence="57">
<disease id="DI-01708">
<name>Hepatocellular carcinoma</name>
<acronym>HCC</acronym>
<description>A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes.</description>
<dbReference type="MIM" id="114550"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21 22 23 54 56">
<disease id="DI-01732">
<name>Renal cell carcinoma papillary</name>
<acronym>RCCP</acronym>
<description>A subtype of renal cell carcinoma tending to show a tubulo-papillary architecture formed by numerous, irregular, finger-like projections of connective tissue. Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium.</description>
<dbReference type="MIM" id="605074"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A common allele in the promoter region of the MET shows genetic association with susceptibility to autism in some families. Functional assays indicate a decrease in MET promoter activity and altered binding of specific transcription factor complexes.</text>
</comment>
<comment type="disease">
<text>MET activating mutations may be involved in the development of a highly malignant, metastatic syndrome known as cancer of unknown primary origin (CUP) or primary occult malignancy. Systemic neoplastic spread is generally a late event in cancer progression. However, in some instances, distant dissemination arises at a very early stage, so that metastases reach clinical relevance before primary lesions. Sometimes, the primary lesions cannot be identified in spite of the progresses in the diagnosis of malignancies.</text>
</comment>
<comment type="disease" evidence="49">
<disease id="DI-04599">
<name>Deafness, autosomal recessive, 97</name>
<acronym>DFNB97</acronym>
<description>A form of non-syndromic sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.</description>
<dbReference type="MIM" id="616705"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="51">
<disease id="DI-04712">
<name>Osteofibrous dysplasia</name>
<acronym>OSFD</acronym>
<description>A congenital disorder of osteogenesis characterized by non-neoplastic, radiolucent lesions that affect the cortical bone immediately under the periosteum. It usually manifests as a painless swelling or anterior bowing of the long bones, most commonly the tibia and fibula.</description>
<dbReference type="MIM" id="607278"/>
</disease>
<text evidence="51">Disease susceptibility is associated with variations affecting the gene represented in this entry. Disease-associated variants identified in 4 families cause the deletion of exon 14. This results in the exclusion of an ubiquitination target site within the cytoplasmic domain, hence in protein stabilization. The persistent presence of MET at the cell surface in conditions of ligand-dependent activation retards osteoblastic differentiation.</text>
</comment>
<comment type="similarity">
<text evidence="18">Belongs to the protein kinase superfamily. Tyr protein kinase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/METID131.html"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/C-MET"/>
<text>C-MET entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="J02958">
<property type="protein sequence ID" value="AAA59591.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X54559">
<property type="protein sequence ID" value="CAB56793.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU826570">
<property type="protein sequence ID" value="ACF47606.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC002080">
<property type="protein sequence ID" value="AAB54047.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC002543">
<property type="protein sequence ID" value="AAC60383.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004416">
<property type="protein sequence ID" value="AAF66137.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH236947">
<property type="protein sequence ID" value="EAL24359.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471070">
<property type="protein sequence ID" value="EAW83509.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC130420">
<property type="protein sequence ID" value="AAI30421.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U08818">
<property type="protein sequence ID" value="AAB60323.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M35074">
<property type="protein sequence ID" value="AAA59590.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS43636.1">
<molecule id="P08581-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47689.1">
<molecule id="P08581-2"/>
</dbReference>
<dbReference type="PIR" id="A40175">
<property type="entry name" value="TVHUME"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000236.2">
<molecule id="P08581-1"/>
<property type="nucleotide sequence ID" value="NM_000245.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001120972.1">
<molecule id="P08581-2"/>
<property type="nucleotide sequence ID" value="NM_001127500.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.132966"/>
<dbReference type="PDB" id="1FYR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="I/J/K/L=1356-1359"/>
</dbReference>
<dbReference type="PDB" id="1R0P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="1R1W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="1SHY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.22"/>
<property type="chains" value="B=25-567"/>
</dbReference>
<dbReference type="PDB" id="1SSL">
<property type="method" value="NMR"/>
<property type="chains" value="A=519-562"/>
</dbReference>
<dbReference type="PDB" id="1UX3">
<property type="method" value="Model"/>
<property type="chains" value="A=25-656"/>
</dbReference>
<dbReference type="PDB" id="2G15">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="2RFN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="2RFS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="2UZX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B/D=25-740"/>
</dbReference>
<dbReference type="PDB" id="2UZY">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="B/D=25-740"/>
</dbReference>
<dbReference type="PDB" id="2WD1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1055-1346"/>
</dbReference>
<dbReference type="PDB" id="2WGJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="2WKM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3A4P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.54"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3BUX">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/C=997-1009"/>
</dbReference>
<dbReference type="PDB" id="3C1X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.17"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3CCN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1048-1350"/>
</dbReference>
<dbReference type="PDB" id="3CD8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1350"/>
</dbReference>
<dbReference type="PDB" id="3CE3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3CTH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3CTJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3DKC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3DKF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3DKG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3EFJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="3EFK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="3F66">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A/B=1052-1349"/>
</dbReference>
<dbReference type="PDB" id="3F82">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3I5N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1350"/>
</dbReference>
<dbReference type="PDB" id="3L8V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="3LQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.02"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3Q6U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=1048-1348"/>
</dbReference>
<dbReference type="PDB" id="3Q6W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1048-1348"/>
</dbReference>
<dbReference type="PDB" id="3QTI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1050-1360"/>
</dbReference>
<dbReference type="PDB" id="3R7O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1048-1348"/>
</dbReference>
<dbReference type="PDB" id="3RHK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A/B=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="3U6H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="3U6I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="3VW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1024-1352"/>
</dbReference>
<dbReference type="PDB" id="3ZBX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3ZC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3ZCL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3ZXZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="3ZZE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="4AOI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="4AP7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1051-1348"/>
</dbReference>
<dbReference type="PDB" id="4DEG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="4DEH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="4DEI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="4EEV">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="4GG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.42"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="4GG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="4IWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.99"/>
<property type="chains" value="A=1048-1348"/>
</dbReference>
<dbReference type="PDB" id="4K3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=39-564"/>
</dbReference>
<dbReference type="PDB" id="4KNB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C/D=1060-1346"/>
</dbReference>
<dbReference type="PDB" id="4MXC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="4O3T">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="B=25-567"/>
</dbReference>
<dbReference type="PDB" id="4O3U">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.04"/>
<property type="chains" value="B=25-567"/>
</dbReference>
<dbReference type="PDB" id="4R1V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.20"/>
<property type="chains" value="A=1055-1345"/>
</dbReference>
<dbReference type="PDB" id="4R1Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1055-1346"/>
</dbReference>
<dbReference type="PDB" id="4XMO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1048-1350"/>
</dbReference>
<dbReference type="PDB" id="4XYF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="5DG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="5EOB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="5EYC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="5EYD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=1048-1351"/>
</dbReference>
<dbReference type="PDB" id="5HLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A=1057-1355"/>
</dbReference>
<dbReference type="PDB" id="5HNI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="X/Y=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="5HO6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="5HOA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.14"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="5HOR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1049-1360"/>
</dbReference>
<dbReference type="PDB" id="5HTI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="A=1038-1346"/>
</dbReference>
<dbReference type="PDB" id="5T3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=1048-1350"/>
</dbReference>
<dbReference type="PDBsum" id="1FYR"/>
<dbReference type="PDBsum" id="1R0P"/>
<dbReference type="PDBsum" id="1R1W"/>
<dbReference type="PDBsum" id="1SHY"/>
<dbReference type="PDBsum" id="1SSL"/>
<dbReference type="PDBsum" id="1UX3"/>
<dbReference type="PDBsum" id="2G15"/>
<dbReference type="PDBsum" id="2RFN"/>
<dbReference type="PDBsum" id="2RFS"/>
<dbReference type="PDBsum" id="2UZX"/>
<dbReference type="PDBsum" id="2UZY"/>
<dbReference type="PDBsum" id="2WD1"/>
<dbReference type="PDBsum" id="2WGJ"/>
<dbReference type="PDBsum" id="2WKM"/>
<dbReference type="PDBsum" id="3A4P"/>
<dbReference type="PDBsum" id="3BUX"/>
<dbReference type="PDBsum" id="3C1X"/>
<dbReference type="PDBsum" id="3CCN"/>
<dbReference type="PDBsum" id="3CD8"/>
<dbReference type="PDBsum" id="3CE3"/>
<dbReference type="PDBsum" id="3CTH"/>
<dbReference type="PDBsum" id="3CTJ"/>
<dbReference type="PDBsum" id="3DKC"/>
<dbReference type="PDBsum" id="3DKF"/>
<dbReference type="PDBsum" id="3DKG"/>
<dbReference type="PDBsum" id="3EFJ"/>
<dbReference type="PDBsum" id="3EFK"/>
<dbReference type="PDBsum" id="3F66"/>
<dbReference type="PDBsum" id="3F82"/>
<dbReference type="PDBsum" id="3I5N"/>
<dbReference type="PDBsum" id="3L8V"/>
<dbReference type="PDBsum" id="3LQ8"/>
<dbReference type="PDBsum" id="3Q6U"/>
<dbReference type="PDBsum" id="3Q6W"/>
<dbReference type="PDBsum" id="3QTI"/>
<dbReference type="PDBsum" id="3R7O"/>
<dbReference type="PDBsum" id="3RHK"/>
<dbReference type="PDBsum" id="3U6H"/>
<dbReference type="PDBsum" id="3U6I"/>
<dbReference type="PDBsum" id="3VW8"/>
<dbReference type="PDBsum" id="3ZBX"/>
<dbReference type="PDBsum" id="3ZC5"/>
<dbReference type="PDBsum" id="3ZCL"/>
<dbReference type="PDBsum" id="3ZXZ"/>
<dbReference type="PDBsum" id="3ZZE"/>
<dbReference type="PDBsum" id="4AOI"/>
<dbReference type="PDBsum" id="4AP7"/>
<dbReference type="PDBsum" id="4DEG"/>
<dbReference type="PDBsum" id="4DEH"/>
<dbReference type="PDBsum" id="4DEI"/>
<dbReference type="PDBsum" id="4EEV"/>
<dbReference type="PDBsum" id="4GG5"/>
<dbReference type="PDBsum" id="4GG7"/>
<dbReference type="PDBsum" id="4IWD"/>
<dbReference type="PDBsum" id="4K3J"/>
<dbReference type="PDBsum" id="4KNB"/>
<dbReference type="PDBsum" id="4MXC"/>
<dbReference type="PDBsum" id="4O3T"/>
<dbReference type="PDBsum" id="4O3U"/>
<dbReference type="PDBsum" id="4R1V"/>
<dbReference type="PDBsum" id="4R1Y"/>
<dbReference type="PDBsum" id="4XMO"/>
<dbReference type="PDBsum" id="4XYF"/>
<dbReference type="PDBsum" id="5DG5"/>
<dbReference type="PDBsum" id="5EOB"/>
<dbReference type="PDBsum" id="5EYC"/>
<dbReference type="PDBsum" id="5EYD"/>
<dbReference type="PDBsum" id="5HLW"/>
<dbReference type="PDBsum" id="5HNI"/>
<dbReference type="PDBsum" id="5HO6"/>
<dbReference type="PDBsum" id="5HOA"/>
<dbReference type="PDBsum" id="5HOR"/>
<dbReference type="PDBsum" id="5HTI"/>
<dbReference type="PDBsum" id="5T3Q"/>
<dbReference type="ProteinModelPortal" id="P08581"/>
<dbReference type="SMR" id="P08581"/>
<dbReference type="BioGrid" id="110391">
<property type="interactions" value="39"/>
</dbReference>
<dbReference type="DIP" id="DIP-6023N"/>
<dbReference type="IntAct" id="P08581">
<property type="interactions" value="87"/>
</dbReference>
<dbReference type="MINT" id="MINT-4837114"/>
<dbReference type="STRING" id="9606.ENSP00000317272"/>
<dbReference type="BindingDB" id="P08581"/>
<dbReference type="ChEMBL" id="CHEMBL3717"/>
<dbReference type="DrugBank" id="DB07969">
<property type="generic name" value="3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol"/>
</dbReference>
<dbReference type="DrugBank" id="DB08875">
<property type="generic name" value="Cabozantinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08865">
<property type="generic name" value="Crizotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB02152">
<property type="generic name" value="K-252a"/>
</dbReference>
<dbReference type="DrugBank" id="DB05216">
<property type="generic name" value="MP470"/>
</dbReference>
<dbReference type="DrugBank" id="DB06995">
<property type="generic name" value="N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB05153">
<property type="generic name" value="XL184"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1815"/>
<dbReference type="iPTMnet" id="P08581"/>
<dbReference type="PhosphoSitePlus" id="P08581"/>
<dbReference type="SwissPalm" id="P08581"/>
<dbReference type="UniCarbKB" id="P08581"/>
<dbReference type="BioMuta" id="MET"/>
<dbReference type="DMDM" id="251757497"/>
<dbReference type="OGP" id="P08581"/>
<dbReference type="EPD" id="P08581"/>
<dbReference type="MaxQB" id="P08581"/>
<dbReference type="PaxDb" id="P08581"/>
<dbReference type="PeptideAtlas" id="P08581"/>
<dbReference type="PRIDE" id="P08581"/>
<dbReference type="DNASU" id="4233"/>
<dbReference type="Ensembl" id="ENST00000318493">
<molecule id="P08581-2"/>
<property type="protein sequence ID" value="ENSP00000317272"/>
<property type="gene ID" value="ENSG00000105976"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000397752">
<molecule id="P08581-1"/>
<property type="protein sequence ID" value="ENSP00000380860"/>
<property type="gene ID" value="ENSG00000105976"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000436117">
<molecule id="P08581-3"/>
<property type="protein sequence ID" value="ENSP00000410980"/>
<property type="gene ID" value="ENSG00000105976"/>
</dbReference>
<dbReference type="GeneID" id="4233"/>
<dbReference type="KEGG" id="hsa:4233"/>
<dbReference type="UCSC" id="uc003vij.4">
<molecule id="P08581-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4233"/>
<dbReference type="DisGeNET" id="4233"/>
<dbReference type="GeneCards" id="MET"/>
<dbReference type="HGNC" id="HGNC:7029">
<property type="gene designation" value="MET"/>
</dbReference>
<dbReference type="HPA" id="CAB005282"/>
<dbReference type="HPA" id="CAB018577"/>
<dbReference type="HPA" id="HPA055607"/>
<dbReference type="MalaCards" id="MET"/>
<dbReference type="MIM" id="114550">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164860">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="605074">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607278">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616705">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08581"/>
<dbReference type="OpenTargets" id="ENSG00000105976"/>
<dbReference type="Orphanet" id="106">
<property type="disease" value="Autism"/>
</dbReference>
<dbReference type="Orphanet" id="47044">
<property type="disease" value="Familial papillary renal cell carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30763"/>
<dbReference type="eggNOG" id="KOG1095">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG3610">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00810000125384"/>
<dbReference type="HOGENOM" id="HOG000220900"/>
<dbReference type="HOVERGEN" id="HBG006348"/>
<dbReference type="InParanoid" id="P08581"/>
<dbReference type="KO" id="K05099"/>
<dbReference type="OMA" id="QRVDLFM"/>
<dbReference type="PhylomeDB" id="P08581"/>
<dbReference type="TreeFam" id="TF317402"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416550">
<property type="pathway name" value="Sema4D mediated inhibition of cell attachment and migration"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6806942">
<property type="pathway name" value="MET Receptor Activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807004">
<property type="pathway name" value="Negative regulation of MET activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851805">
<property type="pathway name" value="MET activates RAS signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851907">
<property type="pathway name" value="MET activates PI3K/AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8865999">
<property type="pathway name" value="MET activates PTPN11"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8874081">
<property type="pathway name" value="MET activates PTK2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875360">
<property type="pathway name" value="InlB-mediated entry of Listeria monocytogenes into host cell"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875513">
<property type="pathway name" value="MET interacts with TNS proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875555">
<property type="pathway name" value="MET activates RAP1 and RAC1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875656">
<property type="pathway name" value="MET receptor recycling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8875791">
<property type="pathway name" value="MET activates STAT3"/>
</dbReference>
<dbReference type="SignaLink" id="P08581"/>
<dbReference type="SIGNOR" id="P08581"/>
<dbReference type="ChiTaRS" id="MET">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P08581"/>
<dbReference type="GeneWiki" id="C-Met"/>
<dbReference type="GenomeRNAi" id="4233"/>
<dbReference type="PRO" id="PR:P08581"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000105976"/>
<dbReference type="CleanEx" id="HS_MET"/>
<dbReference type="ExpressionAtlas" id="P08581">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08581">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009925">
<property type="term" value="C:basal plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005008">
<property type="term" value="F:hepatocyte growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048754">
<property type="term" value="P:branching morphogenesis of an epithelial tube"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001886">
<property type="term" value="P:endothelial cell morphogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035635">
<property type="term" value="P:entry of bacterium into host cell"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061436">
<property type="term" value="P:establishment of skin barrier"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905098">
<property type="term" value="P:negative regulation of guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:1901299">
<property type="term" value="P:negative regulation of hydrogen peroxide-mediated programmed cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035024">
<property type="term" value="P:negative regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0051497">
<property type="term" value="P:negative regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0070495">
<property type="term" value="P:negative regulation of thrombin-activated receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050918">
<property type="term" value="P:positive chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001028">
<property type="term" value="P:positive regulation of endothelial cell chemotaxis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031116">
<property type="term" value="P:positive regulation of microtubule polymerization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071526">
<property type="term" value="P:semaphorin-plexin signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014756">
<property type="entry name" value="Ig_E-set"/>
</dbReference>
<dbReference type="InterPro" id="IPR002909">
<property type="entry name" value="IPT"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR002165">
<property type="entry name" value="Plexin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR016201">
<property type="entry name" value="PSI"/>
</dbReference>
<dbReference type="InterPro" id="IPR001627">
<property type="entry name" value="Semap_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016244">
<property type="entry name" value="Tyr_kinase_HGF/MSP_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01437">
<property type="entry name" value="PSI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01403">
<property type="entry name" value="Sema"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01833">
<property type="entry name" value="TIG"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000617">
<property type="entry name" value="TyrPK_HGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00429">
<property type="entry name" value="IPT"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00423">
<property type="entry name" value="PSI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00630">
<property type="entry name" value="Sema"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF101912">
<property type="entry name" value="SSF101912"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF81296">
<property type="entry name" value="SSF81296"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51004">
<property type="entry name" value="SEMA"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-1010">Non-syndromic deafness</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="17">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Hepatocyte growth factor receptor" id="PRO_0000024440">
<location>
<begin position="25"/>
<end position="1390"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="17">
<location>
<begin position="25"/>
<end position="932"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="17">
<location>
<begin position="933"/>
<end position="955"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="17">
<location>
<begin position="956"/>
<end position="1390"/>
</location>
</feature>
<feature type="domain" description="Sema" evidence="19">
<location>
<begin position="27"/>
<end position="515"/>
</location>
</feature>
<feature type="domain" description="IPT/TIG 1">
<location>
<begin position="563"/>
<end position="655"/>
</location>
</feature>
<feature type="domain" description="IPT/TIG 2">
<location>
<begin position="657"/>
<end position="739"/>
</location>
</feature>
<feature type="domain" description="IPT/TIG 3">
<location>
<begin position="742"/>
<end position="836"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="18">
<location>
<begin position="1078"/>
<end position="1345"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="18">
<location>
<begin position="1084"/>
<end position="1092"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with RANBP9">
<location>
<begin position="1212"/>
<end position="1390"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MUC20" evidence="35">
<location>
<begin position="1320"/>
<end position="1359"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="18 20">
<location>
<position position="1204"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="1110"/>
</location>
</feature>
<feature type="site" description="Cleavage" evidence="17">
<location>
<begin position="307"/>
<end position="308"/>
</location>
</feature>
<feature type="site" description="Required for ligand-induced CBL-mediated ubiquitination" evidence="29">
<location>
<position position="1003"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form TPR-MET oncogene">
<location>
<begin position="1009"/>
<end position="1010"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="966"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="12">
<location>
<position position="977"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 14">
<location>
<position position="990"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="997"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1000"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12 13">
<location>
<position position="1003"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="30">
<location>
<position position="1230"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="30">
<location>
<position position="1234"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="30 38">
<location>
<position position="1235"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="1289"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="30 53">
<location>
<position position="1349"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="37 53">
<location>
<position position="1356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="30">
<location>
<position position="1365"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="45"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="46">
<location>
<position position="106"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="149"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="202"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="399"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="405"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="607"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="635"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="785"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="879"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
<location>
<position position="930"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="95"/>
<end position="101"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="98"/>
<end position="160"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="133"/>
<end position="141"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="298"/>
<end position="363"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="385"/>
<end position="397"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="520"/>
<end position="538"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="526"/>
<end position="561"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="529"/>
<end position="545"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="541"/>
<end position="551"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042447" evidence="58">
<original>SGGSTITGVG</original>
<variation>RHVNIALIQR</variation>
<location>
<begin position="755"/>
<end position="764"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_005005" evidence="59">
<original>S</original>
<variation>STWWKEPLNIVSFLFCFAS</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042448" evidence="58">
<location>
<begin position="765"/>
<end position="1390"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35469582." id="VAR_041738" evidence="42">
<original>R</original>
<variation>Q</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation." id="VAR_064855" evidence="47">
<original>H</original>
<variation>Y</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56311081." id="VAR_041739" evidence="42">
<original>S</original>
<variation>L</variation>
<location>
<position position="156"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs55985569." id="VAR_041740" evidence="42 47">
<original>E</original>
<variation>D</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34349517." id="VAR_032478">
<original>L</original>
<variation>S</variation>
<location>
<position position="238"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35225896." id="VAR_032479">
<original>I</original>
<variation>M</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35776110." id="VAR_006285" evidence="54">
<original>A</original>
<variation>V</variation>
<location>
<position position="320"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs33917957." id="VAR_032480" evidence="42">
<original>N</original>
<variation>S</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs752055485." id="VAR_064856" evidence="47">
<original>C</original>
<variation>Y</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In gastric cancer; dbSNP:rs771333219." id="VAR_032481" evidence="31">
<original>P</original>
<variation>L</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In DFNB97; dbSNP:rs794728016." id="VAR_075757" evidence="49">
<original>F</original>
<variation>V</variation>
<location>
<position position="841"/>
</location>
</feature>
<feature type="sequence variant" description="In OSFD; loss of CBL-mediated destabilization." id="VAR_076584" evidence="51">
<location>
<begin position="964"/>
<end position="1010"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34589476." id="VAR_032482" evidence="39 42">
<original>R</original>
<variation>C</variation>
<location>
<position position="970"/>
</location>
</feature>
<feature type="sequence variant" description="In gastric cancer; prolonged tyrosine phosphorylation in response to HGF/SF; transforming activity in athymic nude mice; dbSNP:rs768678989." id="VAR_032483" evidence="25">
<original>P</original>
<variation>S</variation>
<location>
<position position="991"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation; dbSNP:rs56391007." id="VAR_032484" evidence="25 39 42 47">
<original>T</original>
<variation>I</variation>
<location>
<position position="992"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated mutation found in lesional sample from a patient with sporadically occurring, unilateral osteofibrous dysplasia; somatic mutation; complete loss of ligand-induced CBL-mediated ubiquitination, resulting in protein stabilization." id="VAR_076585" evidence="29">
<original>Y</original>
<variation>S</variation>
<location>
<position position="1003"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; constitutive autophosphorylation; dbSNP:rs786202724." id="VAR_032485" evidence="21 22 23">
<original>V</original>
<variation>I</variation>
<location>
<position position="1092"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines." id="VAR_032486" evidence="21">
<original>H</original>
<variation>L</variation>
<location>
<position position="1094"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; causes malignant transformation in cell lines; dbSNP:rs121913243." id="VAR_032487" evidence="23 56">
<original>H</original>
<variation>R</variation>
<location>
<position position="1094"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines; dbSNP:rs121913244." id="VAR_032488" evidence="21">
<original>H</original>
<variation>Y</variation>
<location>
<position position="1094"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines." id="VAR_032489" evidence="21 23">
<original>H</original>
<variation>D</variation>
<location>
<position position="1106"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; germline mutation; dbSNP:rs121913668." id="VAR_006286" evidence="23 54">
<original>M</original>
<variation>T</variation>
<location>
<position position="1131"/>
</location>
</feature>
<feature type="sequence variant" description="In HCC; dbSNP:rs121913675." id="VAR_032490" evidence="57">
<original>T</original>
<variation>I</variation>
<location>
<position position="1173"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; germline mutation; dbSNP:rs121913669." id="VAR_006287" evidence="23 54">
<original>V</original>
<variation>L</variation>
<location>
<position position="1188"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; somatic mutation; dbSNP:rs121913673." id="VAR_006288" evidence="54">
<original>L</original>
<variation>V</variation>
<location>
<position position="1195"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; germline mutation; dbSNP:rs121913670." id="VAR_006289" evidence="54">
<original>V</original>
<variation>I</variation>
<location>
<position position="1220"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; somatic mutation." id="VAR_006291" evidence="54">
<original>D</original>
<variation>H</variation>
<location>
<position position="1228"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; germline mutation; dbSNP:rs121913671." id="VAR_006290" evidence="54">
<original>D</original>
<variation>N</variation>
<location>
<position position="1228"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; germline mutation; dbSNP:rs121913246." id="VAR_006292" evidence="23 54">
<original>Y</original>
<variation>C</variation>
<location>
<position position="1230"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines." id="VAR_032491" evidence="21 23">
<original>Y</original>
<variation>D</variation>
<location>
<position position="1230"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; somatic mutation; dbSNP:rs121913247." id="VAR_006293" evidence="54">
<original>Y</original>
<variation>H</variation>
<location>
<position position="1230"/>
</location>
</feature>
<feature type="sequence variant" description="In HCC; dbSNP:rs121913677." id="VAR_032492" evidence="57">
<original>K</original>
<variation>R</variation>
<location>
<position position="1244"/>
</location>
</feature>
<feature type="sequence variant" description="In HCC; dbSNP:rs121913676." id="VAR_032493" evidence="57">
<original>M</original>
<variation>I</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="sequence variant" description="In RCCP; somatic mutation; dbSNP:rs121913245." id="VAR_006294" evidence="23 54">
<original>M</original>
<variation>T</variation>
<location>
<position position="1250"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a case of cancer of unknown primary origin; the mutated receptor is still functional and can sustain the transformed phenotype; somatic mutation." id="VAR_064857" evidence="47">
<original>V</original>
<variation>I</variation>
<location>
<position position="1294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of kinase activity and of ligand-induced ubiquitination. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1235." evidence="29 44">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1234"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of kinase activity. Alters interaction with PTPN1 and PTPN2. Loss of interaction with PTPN1 and PTPN2; when associated with F-1234." evidence="29 44">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1235"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1349, F-1356 and F-1365." evidence="29">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1313"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1356 and F-1365." evidence="29">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1349"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1365." evidence="29">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1356"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on ligand-induced CBL-mediated ubiquitination; when associated with F-1313, F-1349 and F-1356." evidence="29">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1365"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; ACF47606." ref="3" evidence="60">
<original>V</original>
<variation>A</variation>
<location>
<position position="237"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; ACF47606." ref="3" evidence="60">
<original>K</original>
<variation>R</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; ACF47606." ref="3" evidence="60">
<original>F</original>
<variation>S</variation>
<location>
<position position="720"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA59591." ref="1" evidence="60">
<original>G</original>
<variation>A</variation>
<location>
<position position="1191"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA59591, 2; CAB56793 and 6; AAA59590." ref="1 2 6" evidence="60">
<original>L</original>
<variation>V</variation>
<location>
<position position="1272"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="45"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="52"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="61"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="69"/>
<end position="74"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="80"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="93"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="97"/>
<end position="99"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="103"/>
<end position="105"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="119"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="125"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="135"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="141"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="155"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="182"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="192"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="213"/>
<end position="219"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="231"/>
<end position="233"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="239"/>
<end position="241"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="242"/>
<end position="244"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="247"/>
<end position="255"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="258"/>
<end position="268"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="277"/>
<end position="281"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="292"/>
<end position="300"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="312"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="316"/>
<end position="323"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="327"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="341"/>
<end position="349"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="356"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="367"/>
<end position="374"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="380"/>
<end position="382"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="383"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="387"/>
<end position="390"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="392"/>
<end position="394"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="395"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="418"/>
<end position="422"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="424"/>
<end position="427"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="429"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="439"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="450"/>
<end position="457"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="462"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="476"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="490"/>
<end position="493"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="496"/>
<end position="498"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="501"/>
<end position="506"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="509"/>
<end position="514"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="518"/>
<end position="521"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="526"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="534"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="538"/>
<end position="540"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="545"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="552"/>
<end position="554"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="557"/>
<end position="559"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="564"/>
<end position="572"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="580"/>
<end position="586"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="590"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="595"/>
<end position="598"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="602"/>
<end position="605"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="614"/>
<end position="616"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="619"/>
<end position="625"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="637"/>
<end position="641"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="646"/>
<end position="650"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="1048"/>
<end position="1050"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="1055"/>
<end position="1057"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1060"/>
<end position="1066"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1067"/>
<end position="1069"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1073"/>
<end position="1075"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1076"/>
<end position="1087"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1090"/>
<end position="1098"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1100"/>
<end position="1102"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1104"/>
<end position="1111"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1118"/>
<end position="1132"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1144"/>
<end position="1146"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="1149"/>
<end position="1151"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1154"/>
<end position="1158"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1165"/>
<end position="1170"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="1172"/>
<end position="1174"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1178"/>
<end position="1197"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1207"/>
<end position="1209"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1210"/>
<end position="1212"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="1218"/>
<end position="1220"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1224"/>
<end position="1226"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1232"/>
<end position="1234"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1236"/>
<end position="1238"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="1239"/>
<end position="1241"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="1243"/>
<end position="1245"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1247"/>
<end position="1249"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1252"/>
<end position="1257"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1262"/>
<end position="1277"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="1283"/>
<end position="1287"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1289"/>
<end position="1291"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1292"/>
<end position="1297"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1310"/>
<end position="1319"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1324"/>
<end position="1326"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="1330"/>
<end position="1342"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1354"/>
<end position="1358"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1R0P"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1SHY"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2UZX"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3F66"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZCL"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EEV"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4K3J"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KNB"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4O3T"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4R1V"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P16056"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255"/>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00352"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10327054"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10417759"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10433944"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454568"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11042681"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11063574"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12147692"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12198496"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12244174"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12475979"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12920089"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14559966"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684163"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15167892"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15314156"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15713673"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15735664"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1655790"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17053076"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1718989"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1719465"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17662939"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18819921"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1917129"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19196183"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20949619"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21784853"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25941349"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26517842"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26637977"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27334921"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7513258"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9140397"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9440692"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9563489"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9927037"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18593464"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2819873"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000305"/>
<evidence key="61" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26637977"/>
</source>
</evidence>
<sequence length="1390" mass="155541" checksum="9CF896D1273905C3" modified="2009-07-07" version="4" precursor="true">
MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEH
HIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMAL
VVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSAL
GAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPE
FRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECIL
TEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRS
AMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEF
TTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFL
LDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGW
CHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKK
TRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVIT
SISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEF
AVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVH
EAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPV
FKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDL
LKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQ
IKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGS
CRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHF
NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL
SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF
VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF
TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW
HPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVD
TRPASFWETS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>